Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
24 04 2020
Historique:
pubmed: 28 3 2020
medline: 1 12 2020
entrez: 28 3 2020
Statut: ppublish

Résumé

There is a growing burden of valvular heart disease (VHD) and atrial fibrillation (AF) due to population aging, but data regarding the characteristics and outcomes of patients with AF and concomitant VHD are lacking.Methods and Results:The Fushimi AF Registry is a community-based prospective survey of AF patients in Fushimi-ku, Kyoto. Among 3,566 patients with available echocardiographic data, 20% had VHD, consisting of 131 valvular AF (VAF: 3.7%) and 583 nonvalvular AF with VHD (NVAF-VHD: 16.3%). Here, VAF was defined as AF with mitral stenosis or a prosthetic heart valve. AF patients with VHD were older, had more comorbidities with a higher CHADS Although VHD did not significantly affect thromboembolism or mortality, it affected cardiac events depending on type, with aortic valve diseases having higher risk, in Japanese patients with AF.

Sections du résumé

BACKGROUND
There is a growing burden of valvular heart disease (VHD) and atrial fibrillation (AF) due to population aging, but data regarding the characteristics and outcomes of patients with AF and concomitant VHD are lacking.Methods and Results:The Fushimi AF Registry is a community-based prospective survey of AF patients in Fushimi-ku, Kyoto. Among 3,566 patients with available echocardiographic data, 20% had VHD, consisting of 131 valvular AF (VAF: 3.7%) and 583 nonvalvular AF with VHD (NVAF-VHD: 16.3%). Here, VAF was defined as AF with mitral stenosis or a prosthetic heart valve. AF patients with VHD were older, had more comorbidities with a higher CHADS
CONCLUSIONS
Although VHD did not significantly affect thromboembolism or mortality, it affected cardiac events depending on type, with aortic valve diseases having higher risk, in Japanese patients with AF.

Identifiants

pubmed: 32213725
doi: 10.1253/circj.CJ-19-1158
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

714-722

Commentaires et corrections

Type : CommentIn

Auteurs

Kosuke Doi (K)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Hisashi Ogawa (H)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Kenjiro Ishigami (K)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Syuhei Ikeda (S)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Yuya Aono (Y)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Yasuhiro Hamatani (Y)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Akiko Fujino (A)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Yoshimori An (Y)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Mitsuru Ishii (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Moritake Iguchi (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Nobutoyo Masunaga (N)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Masahiro Esato (M)

Department of Arrhythmia, Ijinkai Takeda General Hospital.

Hikari Tsuji (H)

Tsuji Clinic.

Hiromichi Wada (H)

Division of Translational Research, National Hospital Organization Kyoto Medical Center.

Koji Hasegawa (K)

Division of Translational Research, National Hospital Organization Kyoto Medical Center.

Mitsuru Abe (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Masaharu Akao (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH